Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-31 @ 1:47 AM
Study NCT ID:
NCT07473193
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-03-16
First Post:
2026-02-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Beetroot Beverage and Repeated Sprint Power Output During RAST
Sponsor:
Universidad Autonoma de Chihuahua
Organization:
Study Overview
Official Title:
"Effects of a Beetroot-Based Functional Beverage on Repeated Sprint Performance: A Randomized, Double-Blind, Placebo-Controlled Crossover Trial"
Status:
NOT_YET_RECRUITING
Status Verified Date:
2026-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This randomized, double-blind, placebo-controlled crossover trial aims to evaluate the acute effects of a nitrate-rich beetroot-based beverage on repeated sprint performance in trained athletes.
Ten athletes will complete two experimental conditions in randomized order: beetroot beverage (BET) and placebo (PLA), separated by a 7-day washout period. The beetroot beverage consists of 200 mL of a mixture containing beetroot, cocoa, and green tea, providing approximately 6.4 mmol of nitrate.
In each condition, participants will perform a Running Anaerobic Sprint Test (RAST), consisting of six maximal 35-meter sprints with 10 seconds of passive recovery between sprints. The primary outcome is mean power output across the six sprints.
Secondary outcomes include fatigue index, sprint-by-sprint power output, heart rate, rating of perceived exertion (Borg 6-20 scale), maximal oxygen uptake (VO₂max), and sleep quality assessed using the Insomnia Severity Index (ISI).
Ten athletes will complete two experimental conditions in randomized order: beetroot beverage (BET) and placebo (PLA), separated by a 7-day washout period. The beetroot beverage consists of 200 mL of a mixture containing beetroot, cocoa, and green tea, providing approximately 6.4 mmol of nitrate.
In each condition, participants will perform a Running Anaerobic Sprint Test (RAST), consisting of six maximal 35-meter sprints with 10 seconds of passive recovery between sprints. The primary outcome is mean power output across the six sprints.
Secondary outcomes include fatigue index, sprint-by-sprint power output, heart rate, rating of perceived exertion (Borg 6-20 scale), maximal oxygen uptake (VO₂max), and sleep quality assessed using the Insomnia Severity Index (ISI).
Detailed Description:
This randomized, double-blind, placebo-controlled crossover trial is designed to investigate the acute effects of a nitrate-rich beetroot-based beverage on repeated sprint performance in trained athletes.
Ten athletes will participate in two experimental sessions in randomized order: beetroot beverage (BET) and placebo (PLA). Randomization will determine the sequence of beverage administration. Participants and investigators will be blinded to treatment allocation.
After beverage ingestion, participants will perform a standardized warm-up followed by the Running Anaerobic Sprint Test (RAST), consisting of six maximal 35-meter sprints with 10 seconds of passive recovery between sprints. Sprint time will be recorded using electronic timing, and power output will be calculated using body mass and sprint time.
The primary outcome measure is mean power output across all six sprints. Secondary outcomes include:
Fatigue index (percentage decrement across sprints)
Individual sprint power (S1-S6)
Heart rate response
Rating of perceived exertion (Borg 6-20 scale)
VO₂max (assessed at baseline)
Sleep quality measured using the Insomnia Severity Index (ISI)
A linear mixed-effects model will be used to analyze repeated sprint performance, including subject as a random intercept and treatment, sprint, and their interaction as fixed effects. Non-parametric tests will be applied when assumptions of normality are not met. Statistical significance will be set at p ≤ 0.05.
Ten athletes will participate in two experimental sessions in randomized order: beetroot beverage (BET) and placebo (PLA). Randomization will determine the sequence of beverage administration. Participants and investigators will be blinded to treatment allocation.
After beverage ingestion, participants will perform a standardized warm-up followed by the Running Anaerobic Sprint Test (RAST), consisting of six maximal 35-meter sprints with 10 seconds of passive recovery between sprints. Sprint time will be recorded using electronic timing, and power output will be calculated using body mass and sprint time.
The primary outcome measure is mean power output across all six sprints. Secondary outcomes include:
Fatigue index (percentage decrement across sprints)
Individual sprint power (S1-S6)
Heart rate response
Rating of perceived exertion (Borg 6-20 scale)
VO₂max (assessed at baseline)
Sleep quality measured using the Insomnia Severity Index (ISI)
A linear mixed-effects model will be used to analyze repeated sprint performance, including subject as a random intercept and treatment, sprint, and their interaction as fixed effects. Non-parametric tests will be applied when assumptions of normality are not met. Statistical significance will be set at p ≤ 0.05.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: